Quick Answer
Addex Therapeutics Ltd. reported Total Assets of $10.68 million for fiscal year 2024.
Addex Therapeutics Ltd. — Key Financials by Year
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Total Assets | $10.68M +130.0% |
$4.64M -44.0% |
$8.28M -63.3% |
$22.54M +11.7% |
$20.18M -38.9% |
$33.03M -21.8% |
| R&D Expense | $854.3K -28.0% |
$1.19M -85.6% |
$8.24M -35.8% |
$12.84M +23.8% |
$10.37M -16.7% |
$12.45M +153.2% |
- Addex Therapeutics Ltd. reported Total Assets of $10.68 million for fiscal year 2024.
- Addex Therapeutics Ltd. showed an increase of +130.0% in Total Assets compared to the prior fiscal year.
- Addex Therapeutics Ltd. reported R&D Expense of $854.3 thousand for fiscal year 2024.
- Addex Therapeutics Ltd. showed a decrease of -28.0% in R&D Expense compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: